However, supplementation with the VV mixture significantly reduced ALT activity and decreased the NAFLD score, indicating improvements in hepatic steatosis and inflammation (Figure 2B–D). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.